<bill session="112" type="h" number="2518" updated="2013-07-20T01:32:06-04:00">
  <state datetime="2011-07-13">REFERRED</state>
  <status>
    <introduced datetime="2011-07-13"/>
  </status>
  <introduced datetime="2011-07-13"/>
  <titles>
    <title as="introduced" type="official">To extend for 5 years the authorization of appropriations for the sickle cell disease prevention and treatment demonstration program.</title>
  </titles>
  <sponsor id="400093"/>
  <cosponsors>
    <cosponsor id="400030" joined="2011-10-26"/>
    <cosponsor id="400373" joined="2011-07-13"/>
    <cosponsor id="400417" joined="2011-10-03"/>
  </cosponsors>
  <actions>
    <action state="REFERRED" datetime="2011-07-13">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2011-07-15">
      <text>Referred to the Subcommittee on Health.</text>
      <committee name="House Committee on Energy and Commerce"/>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" activity="Referral, In Committee"/>
    <committee activity="Referral" code="HSIF14" subcommittee="Health" name="House Energy and Commerce"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Blood and blood diseases"/>
    <term name="Health programs administration and funding"/>
    <term name="Health promotion and preventive care"/>
    <term name="Hereditary and development disorders"/>
  </subjects>
  <amendments/>
  <summary>7/13/2011--Introduced.
Amends the American Jobs Creation Act of 2004 to reauthorize appropriations for FY2013-FY2017 for a demonstration program to develop and establish systemic mechanisms to improve the prevention and treatment of Sickle Cell Disease.</summary>
</bill>
